UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 16, 2016 (August 11, 2016)

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

 (Exact name of registrant as specified in its charter)

 

Nevada   000-55181   46-3951742
(State or other jurisdiction of   (Commission File Number)   (IRS Employer
incorporation)       Identification No.)

 

2255 Glades Road, Suite 342W, Boca Raton, FL   33431
(Address of principal executive offices)    (Zip Code)

 

Registrant’s telephone number, including area code (561) 443-5301

  

 (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

   

Midcap Funding X Trust

 

As previously reported by Twinlab Consolidated Holdings, Inc. (the “Company”) in the Company’s (i) Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 28, 2015, (ii) Current Report on Form 8-K filed with the SEC on February 9, 2015, (iii) Current Report on Form 8-K filed with the SEC on May 6, 2015, (iv) Current Report on Form 8-K filed with the SEC on July 7, 2015, (v) Current Report on Form 8-K filed with the SEC on September 15, 2015, (vi) Current Report on Form 8-K filed with SEC on October 8, 2015, (vii) Current Report on Form 8-K filed with the SEC on February 3, 2016, and (viii) Current Report on Form 8-K filed with the SEC on April 11, 2016, the Company and its direct and indirect wholly owned subsidiaries, Twinlab Consolidation Corporation (“TCC”), Twinlab Holdings, Inc. (“THI”), Twinlab Corporation (“Twinlab”), ISI Brands Inc. (“ISI”), NutraScience Labs, Inc. (“NSL”), NutraScience Labs IP Corporation (“NSLIP”), Organic Holdings LLC (“Organic”), Reserve Life Organics, LLC (“Reserve”), Resvitale, LLC (“Resvitale”), Re-Body, LLC (“Re-Body”), Innovitamin Organics, LLC (“Innovitamin”), Organics Management LLC (“Organics Mgmt.”), Cocoawell, LLC (“Cocoawell”), Fembody, LLC (“Fembody”), Reserve Life Nutrition, L.L.C. (“Reserve Life”), Innovita Speciality Distribution, LLC (“Innovita”) and Joie Essance, LLC (“Joie” and with the Company, TCC, THI, Twinlab, ISI, NSL, NSLIP, Organic, Reserve, Resvitale, Re-Body, Innovitamin, Organics Mgmt., Cocoawell, Fembody, Reserve Life and Innovita, collectively, the “Twinlab Companies”), entered into a Credit and Security Agreement, dated January 22, 2015, with MidCap Financial Trust (“MidCap Trust”), with respect to which Credit and Security Agreement and all related agreements MidCap Trust immediately thereafter assigned all of its rights and interests to MidCap Funding X Trust (“MidCap”), an affiliate of MidCap Trust (as so assigned and subsequently amended by that certain Amendment No. 1 to Credit and Security Agreement and Limited Consent, dated as of February 4, 2015, that certain Amendment No. 2 to Credit Agreement and Limited Consent dated as of April 7, 2015, that certain Amendment No. 3 to Credit and Security Agreement and Limited Consent dated as of April 30, 2015, that certain Amendment No. 4 to Credit and Security Agreement and Limited Waiver dated as of June 30, 2015, that certain Amendment No. 5 to Credit and Security Agreement and Limited Consent, dated as of June 30, 2015, that certain Amendment No. 6 to Credit and Security Agreement, Limited Consent and Limited Waiver dated as of September 9, 2015, that certain Amendment No. 7 and Joinder Agreement to Credit and Security Agreement dated as of October 5, 2015, that certain Amendment No. 8 to Credit and Security Agreement dated as of January 28, 2016, and that certain Amendment No. 9, dated as of April 5, 2016, the “Credit Agreement”).

 

On August 11, 2016, the Twinlab Companies and MidCap entered into an Amendment No. 10 to Credit and Security Agreement (the “MidCap Tenth Amendment”). Pursuant to the MidCap Tenth Amendment several definitions were added to or revised within the Credit Agreement, including to reflect the Unsecured Delayed Draw Promissory Note issued by the Company in favor of Little Harbor, LLC, as previously reported by the Company in the Company’s Current Report on Form 8-K filed with the SEC on July 27, 2016, and, in addition, the financial covenants of the Credit Agreement were replaced in their entirety with the following financial covenants: (i) a Minimum Adjusted EBITDA covenant requiring that beginning with the quarter ended September 30, 2016, and until such time as the Company becomes subject to the Fixed Charge Coverage Ratio covenant described below, the Company shall not at any quarterly measurement period permit Adjusted EBITDA (as defined in the MidCap Tenth Amendment) to be less than the amount set forth for such measurement period in the MidCap Tenth Amendment; (ii) a Fixed Charge Coverage Ratio covenant requiring that the Company shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio (as defined in the Credit Agreement) for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided that, until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance with the Fixed Charge Coverage Ratio covenant shall not be required (and at such time as compliance with the Fixed Charge Coverage Ratio covenant is required, compliance with the Minimum Adjusted EBITDA covenant will no longer be required), and (iii) a Minimum Liquidity covenant requiring that commencing January 1, 2017, the Company shall, as of the end of any month, have Minimum Liquidity (as defined in the MidCap Tenth Amendment) for the test date during the applicable period equal to or in excess of the amount set forth in the MidCap Tenth Amendment for such applicable period. Pursuant to the MidCap Tenth Amendment, MidCap shall have the right at any time in its sole discretion to cause all or any portion of the Minimum Liquidity requirement to be effected as an immediate reserve against the Company’s Borrowing Base (as defined in the Credit Agreement).

 

The foregoing description of the MidCap Tenth Amendment is qualified in its entirety by reference to the full text of such document, which document is an exhibit to this Report.

 

Penta Mezzanine SBIC Fund I, L.P.

 

As previously reported in the Company’s (i) Current Report on Form 8-K filed with the SEC on November 18, 2014, (ii) Current Report on Form 8-K filed with the SEC on January 28, 2015, (iii) Current Report on Form 8-K filed with the SEC on February 9, 2015, (iv) Current Report on Form 8-K filed with the SEC on May 6, 2015, (v) Current Report on Form 8-K filed with the SEC on July 7, 2015, (vi) Current Report on Form 8-K filed with the SEC on September 15, 2015, (vii) Current Report on Form 8-K filed with the SEC on October 8, 2015, (viii) Current Report on Form 8-K filed with the SEC on February 3, 2016, and (ix) Current Report on Form 8-K filed with the SEC on April 11, 2016, the Twinlab Companies entered into a Note and Warrant Purchase Agreement, dated as of November 13, 2014, as amended by that certain First Amendment to Note and Warrant Purchase Agreement, Consent and Joinder dated as of January 22, 2015, as further amended by that certain Second Amendment to Note and Warrant Purchase Agreement and Consent dated as of February 4, 2015, as further amended by that certain Third Amendment to Note and Warrant Purchase Agreement and Consent dated as of April 30, 2015, as further amended by that certain Fourth Amendment to Note and Warrant Purchase Agreement, Limited Consent and Limited Waiver dated as of June 30, 2015, as further amended by that certain Fifth Amendment to Note and Warrant Purchase Agreement and Limited Consent dated as of September 9, 2015, as further amended by that certain Sixth Amendment to Note and Warrant Purchase Agreement dated October 5, 2015, as further amended by that certain Joinder Agreement dated as of October 30, 2015, as further amended by that certain Seventh Amendment to Note and Warrant Purchase Agreement dated as of January 28, 2016, and as further amended by that certain Eighth Amendment to Note and Warrant Purchase Agreement dated April 5, 2016 (as so amended, the “Penta NWPA”), with Penta Mezzanine SBIC Fund I, L.P (“Penta”).

 

 

 

 

On August 11, 2016, the Twinlab Companies and Penta entered into a Ninth Amendment to Note and Warrant Purchase Agreement (the “Ninth Penta Amendment”). Pursuant to the Ninth Penta Amendment, several definitions were added to or revised within the Penta NWPA, including to reflect the Unsecured Delayed Draw Promissory Note issued by the Company in favor of Little Harbor, LLC, as previously reported by the Company in the Company’s Current Report on Form 8-K filed with the SEC on July 27, 2016, and, in addition, the financial covenants of the Penta NWPA were replaced in their entirety with the following financial covenants: (i) a Minimum Adjusted EBITDA covenant requiring that beginning with the quarter ended September 30, 2016, and until such time as the Company becomes subject to the Fixed Charge Coverage Ratio covenant described below, the Company shall not at any quarterly measurement period permit Adjusted EBITDA (as defined in the Ninth Penta Amendment) to be less than the amount set forth for such measurement period in the Ninth Penta Amendment; (ii) a Fixed Charge Coverage Ratio covenant requiring that the Company shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio (as defined in the Penta NWPA) for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided that, until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance with the Fixed Charge Coverage Ratio covenant shall not be required (and at such time as compliance with the Fixed Charge Coverage Ratio covenant is required, compliance with the Minimum Adjusted EBITDA covenant will no longer be required), and (iii) a Minimum Liquidity covenant requiring that commencing January 1, 2017, the Company shall, as of the end of any month, have Minimum Liquidity (as defined in the Ninth Penta Amendment) for the test date during the applicable period equal to or in excess of the amount set forth in the Ninth Penta Amendment for such applicable period.

 

The foregoing description of the Ninth Penta Amendment is qualified in its entirety by reference to the full text of such document, which document is an exhibit to this Report.

 

JL-Mezz Utah, LLC

 

As previously reported in the Company’s (i) Current Report on Form 8-K filed with the SEC on January 28, 2015, (ii) Current Report on Form 8-K filed with the SEC on February 9, 2015, (iii) Current Report on Form 8-K filed with the SEC on May 6, 2015; (iv) Current Report on Form 8-K filed with the SEC on July 7, 2015, (v) Current Report on Form 8-K filed with the SEC on September 15, 2015, (vi) Current Report on Form 8-K filed with the SEC on October 8, 2015, (vii) Current Report on Form 8-K filed with the SEC on February 3, 2016, and (viii) Current Report on Form 8-K filed with the SEC on April 11, 2016, the Twinlab Companies entered into a Note and Warrant Purchase Agreement, dated as of January 22, 2015, as amended by that certain First Amendment to Note and Warrant Purchase Agreement and Consent dated as of February 4, 2015, as further amended by that certain Second Amendment to Note and Warrant Purchase Agreement and Consent dated as of April 30, 2015, as further amended by that certain Third Amendment to Note and Warrant Purchase Agreement, Limited Consent and Limited Waiver dated as of June 30, 2015, as further amended by that certain Fourth Amendment to Note and Warrant Purchase Agreement and Limited Consent dated as of September 9, 2015, as further amended by that certain Fifth Amendment to Note and Warrant Purchase Agreement dated as of October 5, 2015, as further amended by that certain Joinder Agreement dated as of November 10, 2015, as further amended by that that certain Limited Consent dated as of January 5, 2016, as further amended by that certain Sixth Amendment to Note and Warrant Purchase Agreement dated as of January 28, 2016, and as further amended by that certain Seventh Amendment to Note and Warrant Purchase Agreement dated as of April 5, 2016 (as so amended, the “JL NWPA”), with JL-Mezz Utah, LLC (f/k/a JL-BBNC Mezz Utah, LLC) (“JL”).

 

On August 11, 2016, the Twinlab Companies and JL entered into an Eighth Amendment to Note and Warrant Purchase Agreement (the “Eighth JL Amendment”). Pursuant to the Eighth JL Amendment, several definitions were added to or revised within the JL NWPA, including to reflect the Unsecured Delayed Draw Promissory Note issued by the Company in favor of Little Harbor, LLC, as previously reported by the Company in the Company’s Current Report on Form 8-K filed with the SEC on July 27, 2016, and, in addition, the financial covenants of the JL NWPA were replaced in their entirety with the following financial covenants: (i) a Minimum Adjusted EBITDA covenant requiring that beginning with the quarter ended September 30, 2016, and until such time as the Company becomes subject to the Fixed Charge Coverage Ratio covenant described below, the Company shall not at any quarterly measurement period permit Adjusted EBITDA (as defined in the Eighth JL Amendment) to be less than the amount set forth for such measurement period in the Eighth JL Amendment; (ii) a Fixed Charge Coverage Ratio covenant requiring that the Company shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio (as defined in the JL NWPA) for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided that, until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance with the Fixed Charge Coverage Ratio covenant shall not be required (and at such time as compliance with the Fixed Charge Coverage Ratio covenant is required, compliance with the Minimum Adjusted EBITDA covenant will no longer be required), and (iii) a Minimum Liquidity covenant requiring that commencing January 1, 2017, the Company shall, as of the end of any month, have Minimum Liquidity (as defined in the Eighth JL Amendment) for the test date during the applicable period equal to or in excess of the amount set forth in the Eighth JL Amendment for such applicable period.

 

 

 

 

The foregoing description of the Eighth JL Amendment is qualified in its entirety by reference to the full text of such document, which document is an exhibit to this Report.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit 10.144   Amendment No. 10 to Credit and Security Agreement, dated as of August 11, 2016, by and among Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Specialty Distribution, LLC and Joie Essance, LLC and MidCap Funding X Trust.
     
Exhibit 10.145   Ninth Amendment to Note and Warrant Purchase Agreement, dated as of August 11, 2016, by and between Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Speciality Distribution, LLC, and Joie Essance, LLC and Penta Mezzanine SBIC Fund I, L.P.
     
Exhibit 10.146   Eighth Amendment to Note and Warrant Purchase Agreement, dated as of August 11, 2016, by and between Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Speciality Distribution, LLC, and Joie Essance, LLC and JL-Mezz Utah LLC (f/k/a JL-BBNC Mezz Utah, LLC).

 

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

Date: August 16, 2016 TWINLAB CONSOLIDATED HOLDINGS, INC.
     
  By: /s/ William E. Stevens
    William E. Stevens
    Chief Financial Officer

 

 

 

  

EXHIBIT INDEX

 

Exhibit No.   Description
     
Exhibit 10.144   Amendment No. 10 to Credit and Security Agreement, dated as of April 5, 2016, by and among Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Specialty Distribution, LLC and Joie Essance, LLC and MidCap Funding X Trust.
     
Exhibit 10.145   Ninth Amendment to Note and Warrant Purchase Agreement, dated as of April 5, 2016, by and between Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Speciality Distribution, LLC, and Joie Essance, LLC and Penta Mezzanine SBIC Fund I, L.P.
     
Exhibit 10.146   Eighth Amendment to Note and Warrant Purchase Agreement, dated as of April 5, 2016, by and between Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Speciality Distribution, LLC, and Joie Essance, LLC and JL-Mezz Utah LLC (f/k/a JL-BBNC Mezz Utah, LLC).

 

 

 

Exhibit 10.144

 

AMENDMENT NO. 10 TO CREDIT AND SECURITY AGREEMENT

 

THIS AMENDMENT NO. 10 TO CREDIT AND SECURITY AGREEMENT (this “ Amendment ”) is made and entered into as of this 11 th day of August, 2016, but effective as of July 29, 2016, by and among TWINLAB CONSOLIDATED HOLDINGS, INC. , a Nevada corporation (“ TCHI ”), TWINLAB CONSOLIDATION CORPORATION , a Delaware corporation (“ TCC ”), TWINLAB HOLDINGS, INC. , a Michigan corporation, ISI BRANDS INC. , a Michigan corporation, TWINLAB CORPORATION , a Delaware corporation (“ Twinlab Corporation ”), NUTRASCIENCE LABS, INC. , a Delaware corporation (formerly known as TCC CM Subco I, Inc.), NUTRASCIENCE LABS IP CORPORATION , a Delaware corporation (formerly known as TCC CM Subco II, Inc.), ORGANIC HOLDINGS LLC , a Delaware limited liability company, RESERVE LIFE ORGANICS, LLC , a Delaware limited liability company, RESVITALE, LLC , a Delaware limited liability company, RE-BODY, LLC , a Delaware limited liability company, INNOVITAMIN ORGANICS, LLC , a Delaware limited liability company, ORGANICS MANAGEMENT LLC , a Delaware limited liability company, COCOAWELL, LLC , a Delaware limited liability company, FEMBODY, LLC , a Delaware limited liability company, RESERVE LIFE NUTRITION, L.L.C. , a Delaware limited liability company, INNOVITA SPECIALTY DISTRIBUTION, LLC , a Delaware limited liability company, and JOIE ESSANCE, LLC , a Delaware limited liability company (each of the foregoing Persons being referred to herein individually as a “ Borrower ”, and collectively as “ Borrowers ”), and MIDCAP FUNDING X TRUST, a Delaware statutory trust, as successor-by-assignment from MidCap Financial Trust (as Agent for Lenders, “ Agent ”, and individually, as a Lender), and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.

 

RECITALS

 

A.            Pursuant to that certain Credit and Security Agreement dated as of January 22, 2015 by and among Borrowers, Agent and Lenders (as amended by that certain Amendment No. 1 to Credit and Security Agreement and Limited Consent dated as of February 4, 2015, by that certain Amendment No. 2 to Credit and Security Agreement and Limited Consent dated as of April 7, 2015, by that certain Amendment No. 3 to Credit and Security Agreement and Limited Consent dated as of April 30, 2015, by that certain Amendment No. 4 to Credit and Security Agreement and Limited Waiver dated as of June 30, 2015, by that certain Amendment No. 5 to Credit and Security Agreement and Limited Consent dated as of June 30, 2015, by that certain Amendment No. 6 to Credit and Security Agreement, Limited Consent and Limited Waiver dated as of September 9, 2015, by that certain Amendment No. 7 and Joinder Agreement to Credit and Security Agreement dated as of October 5, 2015, by that certain Amendment No. 8 to Credit and Security Agreement dated as of January 28, 2016, by that certain Amendment No. 9 to Credit and Security Agreement dated as of April 5, 2016 and as further amended hereby and as it may be further amended, modified and restated from time to time, the “ Credit Agreement ”), Agent and Lenders agreed to make available to Borrowers a secured revolving credit facility in a principal amount of up to $15,000,000 from time to time (as amended, modified, supplemented, extended and restated from time to time, collectively, the “ Loans ”). Capitalized terms used but not otherwise defined in this Amendment shall have the meanings set forth in the Credit Agreement.

 

 

 

 

AGREEMENT

 

NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Amendment, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and Borrowers hereby agree as follows:

 

1.           Recitals. This Amendment shall constitute a Financing Document and the Recitals set forth above shall be construed as part of this Amendment as if set forth fully in the body of this Amendment.

 

2.           Amendment to Credit Agreement.

 

(a)         Section 1.1 of the Credit Agreement is hereby amended to amend and restate the defined terms “Adjusted EBITDA,” Little Harbor Debt” and “Permitted Debt” in their entirety, respectively, as follows:

 

“Adjusted EBITDA” means EBITDA plus any expenses relating to Acquisitions through the end of Fiscal Year 2015, plus severance payments and other costs relating to permanent headcount reductions, all as determined by GAAP, plus a one-time addback for a non-recurring lease payment to be made in order to terminate the Florida Lease of up to $2,000,000, which termination of the Florida Lease will be on terms and conditions satisfactory to the Agent.

 

“Little Harbor Debt” means the “Subordinated Debt” (as that term is defined in the Subordination Agreement (Little Harbor) and the “Subordinated Loans” (as that term is defined in the July 2016 Subordination Agreement (Little Harbor).

 

Permitted Debt” means: (a) Borrowers’ and its Subsidiaries’ Debt to Agent and each Lender under this Agreement and the other Financing Documents; (b) Debt incurred as a result of endorsing negotiable instruments received in the Ordinary Course of Business; (c) purchase money Debt with respect to equipment, Debt listed on Schedule 5.1, and such other Debt (other than the Essex Lease) not to exceed $3,000,000 at any time (whether in the form of a loan or a Capital Lease) used solely to acquire equipment used in the Ordinary Course of Business and secured only by such equipment; (d) Debt existing on the date of this Agreement and described on Schedule 5.1 and any Refinancing Debt with respect thereto; (e) Debt in the form of insurance premiums financed through the applicable insurance company; (f) trade accounts payable arising and paid on a timely basis and in the Ordinary Course of Business; (g) Subordinated Debt (for the avoidance of doubt, including the Golisano Holdings Debt, Great Harbor Debt, Little Harbor Debt and JL US Debt), (h) the Essex Lease; (i) the Nutricap Seller Notes; (j) the JL Properties Reimbursement Agreement; and (k) the DVA Note, to the extent issued in accordance with the terms of the DVA Put Agreement.

 

 

 

 

(b)         Section 1.1 of the Credit Agreement is hereby amended to add the defined term “July 2016 Subordination Agreement (Little Harbor)” in its alphabetical order as follows:

 

“July 2016 Subordination Agreement (Little Harbor)” means the Subordination Agreement dated as of July 21, 2016 between Agent and Little Harbor, LLC, a Nevada limited liability company, and acknowledged by Borrowers, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 

(c)         Section 6.1 of the Credit Agreement is hereby amended to add the defined term “Minimum Liquidity” in its alphabetical order as follows:


Minimum Liquidity means the sum of Revolving Loan Availability plus cash and cash equivalents that are (a) owned by any Borrower, and (b) not subject to any Lien other than a Lien in favor of Agent, excluding, however, any cash and cash equivalents in a specified amount pledged to or held by Agent to secure a specified Obligation in that amount. For the avoidance of doubt, cash and cash equivalents that in accordance with this Agreement secure the Loans generally are not excluded except to the extent so specified.

 

(d)         Section 6.2 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 

Minimum Adjusted EBITDA . Commencing with the quarter ending September 30, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Borrowers shall not, as of the end of any measurement period set forth below, permit the Adjusted EBITDA for such measurement period to be less than the amount set forth in the table below opposite such measurement period; provided , however , if (i) no Event of Default exists and (ii) the Fixed Charge Coverage Ratio, as determined in Section 6.3, exceeds 1.00x for three consecutive monthly test dates, Minimum Adjusted EBITDA shall no longer be tested under this Section 6.2.

 

 

 

 

Measurement Period   Minimum Adjusted EBITDA  
April 1, 2016 to September 30, 2016   $ -1,800,000  
April 1, 2016 to December 31, 2016   $ -2,700,000  
April 1, 2016 to March 31, 2017   $ -3,300,000  
July 1, 2016 to June 30, 2017   $ -2,400,000  
October 1, 2016 to September 30, 2017   $ -2,900,000  
January 1, 2017 to December 31, 2017   $ -1,900,000  
April 1, 2017 to March 31, 2018   $ -1,100,000  
July 1, 2017 to June 30, 2018   $ 0  
October 1, 2017 to September 30, 2018   $ 700,000  
January 1, 2018 to December 31, 2018   $ 1,400,000  

 

(e)         Section 6.3 of the Credit Agreement is hereby amended and restated in its entirety as follows:

 

Fixed Charge Coverage Ratio . Commencing August 31, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Borrowers shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided , however , that until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance shall not be required with respect to the Fixed Charge Coverage Ratio financial covenant in this Section 6.3 but such financial covenant shall still be tested as of the end of each month.

 

(f)         Section 6.4 is hereby amended and restated in its entirety as follows:

 

Minimum Liquidity . Commencing January 1, 2017 and until such time as all Obligations are paid, satisfied and discharged in full, the Borrowers shall at all times, as tested as of the end of any month, have Minimum Liquidity for the test date during the applicable period equal to or in excess of than the amount set forth in the table below opposite such applicable period:

 

 

 

 

Applicable Period   Minimum Liquidity  
January 1, 2017 to March 31, 2017   $ 500,000  
April 1, 2017 to June 30, 2017   $ 1,000,000  
July 1, 2017 and all times thereafter   $ 1,500,000  

 

Without limiting any other rights of the Agent hereunder to institute reserves, including, but not limited to, Section 2.1(b)(i), Agent shall at any time be permitted in its sole discretion to cause all or any portion of the Minimum Liquidity requirement to be effected as an immediate reserve against the Borrowing Base.

 

(g)         Exhibit B to the Credit Agreement containing a Form of Compliance Certificate is hereby amended and restated as set forth on Exhibit B attached to and made a part of this Amendment.

 

3.           Confirmation of Representations and Warranties; Reaffirmation of Security Interest. Each Borrower hereby (a) confirms that all of the representations and warranties set forth in the Credit Agreement are true and correct with respect to such Borrower as of the date hereof, and (b) covenants to perform its respective obligations under the Credit Agreement. Each Borrower confirms and agrees that all security interests and Liens granted to Agent continue in full force and effect, and all Collateral remains free and clear of any Liens, other than those granted to Agent and Permitted Liens. Nothing herein is intended to impair or limit the validity, priority or extent of Agent’s security interests in and Liens on the Collateral.

 

4.           Enforceability. This Amendment constitutes the legal, valid and binding obligation of each Borrower, and is enforceable against each Borrower in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the enforcement of creditors’ rights generally and by general equitable principles.

 

5.           Costs and Fees . In consideration of Agent’s agreement to enter into this Amendment, Borrower shall pay to Agent a modification fee equal to Fifty Thousand and No/100 Dollars ($50,000.00). Furthermore, Borrowers shall be responsible for the payment of all reasonable costs and fees of Agent’s counsel incurred in connection with the preparation of this Amendment and any related documents. If Agent or any Lender uses in-house counsel for any of these purposes, Borrowers further agree that the Obligations include reasonable charges for such work commensurate with the fees that would otherwise be charged by outside legal counsel selected by Agent or such Lender for the work performed. Borrowers hereby authorize Agent to deduct all of such fees set forth in this Section 8 from the proceeds of one or more Revolving Loans made under the Credit Agreement.

 

6.           Conditions to Effectiveness. This Amendment shall become effective as of the date on which each of the following conditions has been satisfied (the “ Effective Date ”):

 

 

 

 

(a)          Borrowers shall have delivered to Agent this Amendment, duly executed by an authorized officer of each Borrower;

 

(b)          all representations and warranties of Borrowers contained herein shall be true and correct in all material respects as of the Effective Date (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof); and

 

(c)          Borrowers shall have delivered to Agent evidence that any Subordinated Debt of the Borrowers that has financial covenants shall have been amended to match the financial covenants found in this Amendment and include no additional financial covenants;

 

(d)          Agent shall have received from Borrowers of all of the fees owing pursuant to this Amendment and Agent’s reasonable out-of-pocket legal fees and expenses.

 

7.           Release. Each Borrower, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “ Releasing Parties ”), does hereby fully and completely release, acquit and forever discharge each Indemnitee of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnitees (or any of them) that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “ Prior Related Event ” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any of the terms of this Amendment or any other Financing Document, (b) any actions, transactions, matters or circumstances related hereto or thereto, (c) the conduct of the relationship between any Indemnitee and any Borrower, or (d) any other actions or inactions by any Indemnitee, all on or prior to the Effective Date. Each Borrower acknowledges that the foregoing release is a material inducement to Agent’s and Lender’s decision to enter into this Amendment and to agree to the modifications contemplated hereunder.

 

8.           No Waiver or Novation. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided in this Amendment, operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection with any of the foregoing. Except as expressly provided herein, nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events of Default under the Credit Agreement or other Financing Documents or any of Agent’s rights and remedies in respect of such Defaults or Events of Default. This Amendment (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement.

 

 

 

 

9.          Affirmation. Except as specifically amended and waived pursuant to the terms hereof, the Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and confirmed in all respects by Borrowers. Each Borrower covenants and agrees to comply with all of the terms, covenants and conditions of the Credit Agreement (as amended hereby) and the Financing Documents, notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent’s or any Lender’s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions.

 

10.         Miscellaneous.

 

(a)         Reference to the Effect on the Credit Agreement. Upon the effectiveness of this Amendment, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this Amendment. Except as specifically amended and waived above, the Credit Agreement, and all other Financing Documents (and all covenants, terms, conditions and agreements therein), shall remain in full force and effect, and are hereby ratified and confirmed in all respects by Borrowers.

 

(b)           Incorporation of Credit Agreement Provisions. The provisions contained in Section 11.6 (Indemnification), Section 12.8 (Governing Law; Submission to Jurisdiction) and Section 12.9 (Waiver of Jury Trial) of the Credit Agreement are incorporated herein by reference to the same extent as if reproduced herein in their entirety.

 

(c)           Headings. Section headings in this Amendment are included for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.

 

(d)           Counterparts. This Amendment may be signed in any number of counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic version (e.g., .pdf or .tif file) of an executed signature page shall be treated as delivery of an original and shall bind the parties hereto. This Amendment constitutes the entire agreement and understanding among the parties hereto and supersede any and all prior agreements and understandings, oral or written, relating to the subject matter hereof.

 

[SIGNATURES APPEAR ON FOLLOWING PAGES]

 

 

 

 

( Signature Page to Amendment No. 10 to Credit and Security Agreement )

 

IN WITNESS WHEREOF , intending to be legally bound, and intending that this document constitute an agreement executed under seal, the undersigned have executed this Amendment under seal as of the day and year first hereinabove set forth.

 

AGENT: MIDCAP FUNDING X TRUST, a Delaware
  statutory trust, as successor-by-assignment from
  MidCap Financial Trust
     
  By: Apollo Capital Management, L.P.,
    its investment manager
     
  By: Apollo Capital Management GP, LLC,
    its general partner
     
  By: /s/ Maurice Amsellem          (SEAL)
  Name: Maurice Amsellem
  Title: Authorized Signatory
     
LENDER: MIDCAP FUNDING X TRUST, a Delaware
  statutory trust, as successor-by-assignment from
  MidCap Financial Trust
     
  By: Apollo Capital Management, L.P.,
    its investment manager
     
  By: Apollo Capital Management GP, LLC,
    its general partner
     
  By: /s/ Maurice Amsellem          (SEAL)
  Name: Maurice Amsellem
  Title: Authorized Signatory

 

 

 

 

( Signature Page to Amendment No. 10 to Credit and Security Agreement )

 

BORROWERS:  

TWINLAB CONSOLIDATION

CORPORATION

     
    By: /s/ Naomi Whittel (Seal)
    Name:  Naomi Whittel
    Title:    Chief Executive Officer
     
     
TWINLAB CONSOLIDATED HOLDINGS, INC.   TWINLAB HOLDINGS, INC.
     
By:   /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Chief Executive Officer   Title:    Chief Executive Officer
     
TWINLAB CORPORATION   ISI BRANDS INC.
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Chief Executive Officer   Title:    Chief Executive Officer
     
NUTRASCIENCE LABS, INC.   NUTRASCIENCE LABS IP CORPORATION
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Chief Executive Officer   Title:    Chief Executive Officer
     
ORGANIC HOLDINGS LLC   RESERVE LIFE ORGANICS, LLC
     
By: /s/ Naomi Whittel (Seal)   By ORGANIC HOLDINGS LLC,
Name:  Naomi Whittel   its sole Member
Title:    Sole Manager    
    By: /s/ Naomi Whittel (Seal)
    Name:  Naomi Whittel
    Title:    Sole Manager

 

 

 

   

(Signature Page to Amendment No. 10 to Credit and Security Agreement)

 

RESVITALE, LLC   RE-BODY, LLC
     
By ORGANIC HOLDINGS LLC,   By ORGANIC HOLDINGS LLC,
its sole Member   its sole Member
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Sole Manager   Title:    Sole Manager
     
INNOVITAMIN ORGANICS, LLC   ORGANICS MANAGEMENT LLC
     
By ORGANIC HOLDINGS LLC,   By ORGANIC HOLDINGS LLC,
its sole Member   its sole Member
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Sole Manager   Title:    Sole Manager
     
COCOAWELL, LLC   FEMBODY, LLC
     
By ORGANIC HOLDINGS LLC,   By ORGANIC HOLDINGS LLC,
its sole Member   its sole Member
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Sole Manager   Title:    Sole Manager
     
RESERVE LIFE NUTRITION, L.L.C.   INNOVITA SPECIALTY DISTRIBUTION, LLC
     
By ORGANIC HOLDINGS LLC,   By ORGANIC HOLDINGS LLC,
its sole Member   its sole Member
     
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name:  Naomi Whittel   Name:  Naomi Whittel
Title:    Sole Manager   Title:    Sole Manager
     
JOIE ESSANCE, LLC    
     
By ORGANIC HOLDINGS LLC,    
its sole Member    
     
By: /s/ Naomi Whittel (Seal)    
Name:  Naomi Whittel    
Title:    Sole Manager  

 

 

 

 

Exhibit B to Credit Agreement (FORM OF Compliance Certificate)

 

COMPLIANCE CERTIFICATE

 

This Compliance Certificate is given by _____________________, a Responsible Officer of TWINLAB CONSOLIDATION CORPORATION (the “ Borrower Representative ”), pursuant to that certain Credit and Security Agreement dated as of January 22, 2015 among the Borrower Representative, TWINLAB CONSOLIDATED HOLDINGS, INC., TWINLAB HOLDINGS, INC., ISI BRANDS INC., TWINLAB CORPORATION, NUTRASCIENCE LABS, INC.(formerly known as TCC CM Subco I, Inc.), NUTRASCIENCE LABS IP CORPORATION (formerly known as TCC CM Subco II, Inc.), ORGANIC HOLDINGS LLC, RESERVE LIFE ORGANICS, LLC, RESVITALE, LLC, RE-BODY, LLC, INNOVITAMIN ORGANICS, LLC, ORGANICS MANAGEMENT LLC, COCOAWELL, LLC, FEMBODY, LLC, RESERVE LIFE NUTRITION, L.L.C., INNOVITA SPECIALTY DISTRIBUTION, LLC, JOIE ESSANCE, LLC and any additional Borrower that may hereafter be added thereto (collectively, “ Borrowers ”), MidCap Funding X Trust (as successor by assignment from MidCap Financial Trust), individually as a Lender and as Agent, and the financial institutions or other entities from time to time parties hereto, each as a Lender (as such agreement may have been amended, restated, supplemented or otherwise modified from time to time, the “ Credit Agreement ”). Capitalized terms used herein without definition shall have the meanings set forth in the Credit Agreement.

 

The undersigned Responsible Officer hereby certifies to Agent and Lenders that:

 

(a)          the financial statements delivered with this certificate in accordance with Section 4.1 of the Credit Agreement fairly present in all material respects the results of operations and financial condition of Borrowers and their Consolidated Subsidiaries as of the dates and the accounting period covered by such financial statements;

 

(b)          I have reviewed the terms of the Credit Agreement and have made, or caused to be made under my supervision, a review in reasonable detail of the transactions and conditions of Borrowers and their Consolidated Subsidiaries during the accounting period covered by such financial statements and such review has not disclosed the existence during or at the end of such accounting period, and I have no knowledge of the existence as of the date hereof, of any condition or event that constitutes a Default or an Event of Default, except as set forth in Schedule 1 hereto, which includes a description of the nature and period of existence of such Default or an Event of Default and what action Borrowers have taken, are undertaking and propose to take with respect thereto;

 

(c)          except as noted on Schedule 2 attached hereto, the Credit Agreement contains a complete and accurate list of all business locations of Borrowers and Guarantors and all names under which Borrowers and Guarantors currently conduct business; Schedule 2 specifically notes any changes in the names under which any Borrower or Guarantor conduct business;

 

(d)          except as noted on Schedule 3 attached hereto, the undersigned has no knowledge of (i) any federal or state tax liens having been filed against any Borrower, Guarantor or any Collateral or (ii) any failure of any Borrower or Guarantors to make required payments of withholding or other tax obligations of any Borrower or Guarantors during the accounting period to which the attached statements pertain or any subsequent period.

 

 

 

 

(e)          Schedule 5.14 to the Credit Agreement contains a complete and accurate statement of all deposit accounts and investment accounts maintained by Borrowers and Guarantors;

 

(f)          except as noted on Schedule 4 attached hereto and Schedule 3.6 to the Credit Agreement, the undersigned has no knowledge of any current, pending or threatened: (i) litigation against any Borrower or Guarantor; (ii)         inquiries, investigations or proceedings concerning the business affairs, practices, licensing or reimbursement entitlements of any Borrower or Guarantor; or (iii) any default by any Borrower or Guarantor under any Material Contract to which it is a party.

 

(g)          except as noted on Schedule 5 attached hereto, no Borrower or Guarantor has acquired, by purchase, by the approval or granting of any application for registration (whether or not such application was previously disclosed to Agent by Borrowers) or otherwise, any Intellectual Property that is registered with any United States or foreign Governmental Authority, or has filed with any such United States or foreign Governmental Authority, any new application for the registration of any Intellectual Property, or acquired rights under a license as a licensee with respect to any such registered Intellectual Property (or any such application for the registration of Intellectual Property) owned by another Person, that has not previously been reported to Agent on Schedule 3.17 to the Credit Agreement or any Schedule 5 to any previous Compliance Certificate delivered by the Company to Agent.

 

(j)          except as noted on Schedule 6 attached hereto, no Borrower or Guarantor has acquired, by purchase or otherwise, any Chattel Paper, Letter of Credit Rights, Instruments, Documents or Investment Property that has not previously been reported to Agent on any Schedule 6 to any previous Compliance Certificate delivered by Borrower Representative to Agent.

 

(k)          except as noted on Schedule 7 attached hereto, no Borrower or Guarantor is aware of any commercial tort claim that has not previously been reported to Agent on any Schedule 7 to any previous Compliance Certificate delivered by Borrower Representative to Agent.

 

(l)          Borrowers and Guarantors (if any) are in compliance with the covenants contained in Article 6 of the Credit Agreement, and in any Guarantee constituting a part of the Financing Documents, as demonstrated by the calculation of such covenants below, except as set forth below; in determining such compliance, the following calculations have been made: [See attached worksheets]. Such calculations and the certifications contained therein are true, correct and complete.

 

 

 

 

The foregoing certifications and computations are made as of ________________, 201__ (end of month) and as of _____________, 201__.

 

  Sincerely,
   
 

TWINLAB CONSOLIDATION

CORPORATION

   
  By:     
  Name:  
  Title:    

 

 

 

 

Adjusted EBITDA Worksheet (Attachment to Compliance Certificate)

 

EBITDA for the applicable period is calculated as follows, in each case, determined on a consolidated basis in accordance with GAAP:        
         
Net Income for the period of the Borrowers, being the consolidated net income (or loss) of the Borrowers and their Subsidiaries for the period in question, after giving effect to deduction for provision for all operating expenses, all taxes and reserves (including reserves for deferred taxes) and all other proper deductions, all determined in accordance with GAAP; provided, however, that for purposes of calculating Net Income, there shall be excluded and no effect shall be given to (a) one-time extraordinary income items, as determined in accordance with GAAP, and (b) any Net Income attributable to any Subsidiary to the extent that any Borrower (or any Subsidiary through which such Borrower owns the subject Subsidiary) is prohibited (bylaw, contract minority ownership rights or otherwise) from receiving a distribution of such Net Income from such Subsidiary:   $  
         
Minus :   Any extraordinary gains, interest income, non-operating income, non-cash income and income tax benefits and decreases in any change in LIFO or any other inventory reserves for the period   $  
         
Plus :      non-cash extraordinary losses (including non-cash expenses with respect to stock option and stock based employee compensation programs), Interest Expense, income taxes, depreciation and amortization and increases in any change in LIFO reserves for the period   $  
         
EBITDA for the Defined Period:   $  
         

Plus : any expenses relating to Acquisitions through the end of Fiscal Year 2015, plus severance payments and other costs relating to permanent headcount reductions, all as determined by GAAP, plus a one-time addback for a non-recurring lease payment to be made in order to terminate the Florida Lease of up to $2,000,000, which termination of the Florida Lease will be on terms and conditions satisfactory to the Agent.

 

  $  
         
Adjusted EBITDA for the Defined Period   $  

 

 

 

 

Fixed Charge Coverage Ratio Worksheet (Attachment to Compliance Certificate)

 

Fixed Charge Coverage Ratio for the applicable period is calculated as the ratio of:
       
         
Adjusted EBITDA for the period (calculated pursuant to the Adjusted EBITDA Worksheet)   $    
         
Plus :      cash received during such period for Equity Interests so long as such cash is used as working capital and such cash is not received more than two times in any trailing-twelve-months period $    
         
Minus :   Capital Expenditures not financed by the seller of the capital asset or by a third party lender made (to the extent not already incurred in a prior period) or incurred during such period   $    
         
Minus :   cash taxes paid during such period, to the extent greater than zero   $    
         
Minus :   Permitted Distributions under clause (d) of the definition of that term   $    
         
Total for the period:   $    
         
To        
         
Fixed Charges for the applicable period, which is calculated with respect to the Borrowers and their Subsidiaries determined on a consolidated basis in accordance with GAAP, the sum, without duplication, as follows:        
         
Cash Interest Expense paid during such period (other than interest paid-in-kind, amortization of financing fees, and other non-cash Interest Expense),   $    
         
Plus :      principal payments paid in cash in respect of Debt paid during such period, including cash payments with respect to Capital Leases, but excluding principal payments made on the Revolving Loans   $    
         
Plus :      all Permitted Distributions (other than Permitted Distributions under clause (d) of the definition of that term) and other distributions paid in cash during such period   $    
         
Fixed Charges for the applicable period:   $    
         
Ratio:        

 

 

 

Minimum Liquidity Worksheet (Attachment to Compliance Certificate)

 

Revolving Loan Availability plus cash and cash equivalents that are (a) owned by any Borrower, and (b) not subject to any Lien other than a Lien in favor of Agent, excluding, however, any cash and cash equivalents in a specified amount pledged to or held by Agent to secure a specified Obligation in that amount.   $  

 

 

 

 

Covenant Compliance:        
         
Minimum Adjusted EBIDTA   $  
         
Minimum Fixed Charge Coverage Ratio for the period     ___ to 1.0  
         
Minimum Liquidity   $  
         
In Compliance     Yes/No  

 

 

 

Exhibit 10.145

 

NINTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

 

This NINTH AMENDMENT TO NOTE AND WARRANT AGREEMENT (this “ Amendment ”), dated as of August 11, 2016, but effective as of July 29, 2016, is made by and between TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (“ Parent ”), TWINLAB CONSOLIDATION CORPORATION, a Delaware corporation (“ TCC ”), TWINLAB HOLDINGS, INC., a Michigan corporation (“ Twinlab Holdings ”), ISI BRANDS INC., a Michigan corporation (“ ISI Brands ”), and TWINLAB CORPORATION, a Delaware corporation (“ Twinlab Corporation ”), NUTRASCIENCE LABS, INC., a Delaware corporation, NUTRASCIENCE LABS IP CORPORATION., a Delaware corporation, ORGANIC HOLDINGS LLC, a Delaware limited liability company, RESERVE LIFE ORGANICS, LLC, a Delaware limited liability company, RESVITALE, LLC, a Delaware limited liability company, RE-BODY, LLC, a Delaware limited liability company, INNOVITAMIN ORGANICS, LLC, a Delaware limited liability company, ORGANICS MANAGEMENT LLC, a Delaware limited liability company, COCOAWELL, LLC, a Delaware limited liability company, FEMBODY, LLC, a Delaware limited liability company, RESERVE LIFE NUTRITION, L.L.C., a Delaware limited liability company, INNOVITA SPECIALTY DISTRIBUTION, LLC, a Delaware limited liability company, and JOIE ESSANCE, LLC, a Delaware limited liability company (each of the foregoing Persons being referred to herein individually as a “ Company ” and collectively as the “ Companies ”), and PENTA MEZZANINE SBIC FUND I, L.P., a Delaware limited partnership (the “ Purchaser ”).

 

WHEREAS, the Companies and the Purchaser are parties to a Note and Warrant Purchase Agreement dated as of November 13, 2014, as amended by that certain First Amendment to Note and Warrant Purchase Agreement, Consent and Joinder dated as of January 22, 2015, that certain Second Amendment to Note and Warrant Purchase Agreement and Consent dated as of February 4, 2015, that certain Third Amendment to Note and Warrant Purchase Agreement and Consent dated as of April 30, 2015, that certain Fourth Amendment to Note and Warrant Purchase Agreement, Limited Consent and Limited Waiver dated as of June 30, 2015, that certain Fifth Amendment to Note and Warrant Purchase Agreement and Limited Consent dated as of September 9, 2015, that certain Sixth Amendment to Note and Warrant Purchase Agreement dated October 5, 2015, that certain Joinder Agreement dated as of October 30, 2015, that certain Seventh Amendment to Note and Warrant Purchase Agreement dated as of January 28, 2016 and that certain Eighth Amendment to Note and Warrant Purchase Agreement dated as of April 5, 2016 (as the same may be further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ Note Purchase Agreement ”); and

 

NOW, THEREFORE, in consideration of the promises and the mutual agreements contained in this Amendment, and subject to the terms and conditions set forth herein, each party hereto hereby agrees as follows:

 

1.           Capitalized Terms . Capitalized terms used but not defined herein shall have the meanings set forth in the Note Purchase Agreement.

 

2.           Amendments to Note Purchase Agreement . Subject to the satisfaction of the conditions precedent set forth herein and in reliance on the representations, warranties and covenants of the Companies set forth herein and in the Note Purchase Agreement, each party hereto hereby agrees that the Note Purchase Agreement be and hereby is, amended as follows:

 

2.1.        Amendment to Defined Terms . Section 1 of the Note Purchase Agreement is hereby amended to amend and restate the defined terms “Adjusted EBITDA” and “Little Harbor Debt” in their entirety, respectively, as follows:

 

  1  

 

 

Adjusted EBITDA ” means EBITDA plus any expenses relating to Acquisitions through the end of Fiscal Year 2015, plus severance payments and other costs relating to permanent headcount reductions, all as determined by GAAP, plus a one-time addback for a non-recurring lease payment to be made in order to terminate the Florida Lease of up to $2,000,000, which termination of the Florida Lease will be on terms and conditions satisfactory to the Purchaser.

 

Little Harbor Debt ” means the “Subordinated Debt” (as that term is defined in the Little Harbor Subordination Agreement) and the “Subordinated Loans” (as that term is defined in the July 2016 Little Harbor Subordination Agreement).

 

2.2.        New Defined Terms . Section 1 of the Note Purchase Agreement is hereby amended by inserting the following defined terms in the appropriate alphabetical order:

 

July 2016 Little Harbor Subordination Agreement ” means the Subordination Agreement dated as of July 21, 2016 between the Purchaser and Little Harbor, LLC, a Nevada limited liability company, and acknowledged by the Companies, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 

Minimum Liquidity ” means the sum of Revolving Loan Availability (as defined in the Senior Loan Documents) plus cash and cash equivalents that are (a) owned by any Company, and (b) not subject to any Lien other than a Lien in favor of the Senior Lender, excluding, however, any cash and cash equivalents in a specified amount pledged to or held by the Senior Lender to secure a specified Obligation (as defined in the Senior Loan Documents) in that amount. For the avoidance of doubt, cash and cash equivalents that in accordance with the Senior Loan Documents secure the Permitted Senior Debt generally are not excluded except to the extent so specified.

 

2.3.        Amendment to Section 5.12(a) . Section 5.12(a) of the Note Purchase Agreement is hereby amended and restated in its entirety as follows:

 

“(a)           Minimum Adjusted EBITDA . Commencing with the fiscal quarter ending September 30, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall not, as of the end of any measurement period set forth below, permit the Adjusted EBITDA for such measurement period to be less than the amount set forth in the table below opposite such measurement period; provided , however , if (i) no Event of Default exists and (ii) the Fixed Charge Coverage Ratio, as determined in Section 5.12(b), exceeds 1.00x for three consecutive monthly test dates, Minimum Adjusted EBITDA shall no longer be tested under this Section 5.12(a).

 

 

Measurement Period   Minimum Adjusted EBITDA  
April 1, 2016 to September 30, 2016   $ -1,800,000  
April 1, 2016 to December 31, 2016   $ -2,700,000  
April 1, 2016 to March 31, 2017   $ -3,300,000  
July 1, 2016 to June 30, 2017   $ -2,400,000  
October 1, 2016 to September 30, 2017   $ -2,900,000  
January 1, 2017 to December 31, 2017   $ -1,900,000  
April 1, 2017 to March 31, 2018   $ -1,100,000  
July 1, 2017 to June 30, 2018   $ 0  
October 1, 2017 to September 30, 2018   $ 700,000  
January 1, 2018 to December 31, 2018   $ 1,400,000”  

 

  2  

 

 

2.4.        Amendment to Section 5.12(b) . Section 5.12(b) of the Note Purchase Agreement is hereby amended by replacing Section 5.12(b) in its entirety with the following:

 

“(b)           Fixed Charge Coverage Ratio . Commencing August 31, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided , however , that until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance shall not be required with respect to the Fixed Charge Coverage Ratio financial covenant in this Section 5.12(b) but such financial covenant shall still be tested as of the end of each month.”

 

2.5.        Amendment to Section 5.12(c) . Section 5.12(c) of the Note Purchase Agreement is hereby amended by replacing Section 5.12(c) in its entirety with the following:

 

“(c)           Minimum Liquidity . Commencing January 1, 2017 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall at all times, as tested as of the end of any month, have Minimum Liquidity for the test date during the applicable period equal to or in excess of than the amount set forth in the table below opposite such applicable period.

 

Applicable Period   Minimum Liquidity  
January 1, 2017 to March 31, 2017   $ 500,000  
April 1, 2017 to June 30, 2017   $ 1,000,000  
July 1, 2017 and all times thereafter   $ 1,500,000”  

 

2.6.        Amendment to Section 6.11 . Section 6.11 of the Note Purchase Agreement is hereby amended by replacing Section 6.11 in its entirety with the following:

 

6.11         Entering Into or Modification of Certain Agreements

 

The Companies and their Subsidiaries shall not amend, restate, supplement or otherwise modify (or permit or consent to any amendment, restatement, supplement or modification of) the terms of (i) its articles or certificate of incorporation, bylaws, any agreement between or among any of the holders of any Company’s or any of its Subsidiaries’ Equity Interests, any other organizational document, in each case which would be materially adverse to the Purchaser and (ii) any of the Transaction Documents, the documents and/or instruments evidencing the Permitted Senior Debt (unless permitted under the Subordination Agreement), the documents and/or instruments evidencing the Little Harbor Debt (unless permitted under the Little Harbor Subordination Agreement or the July 2016 Little Harbor Subordination Agreement, as applicable), the Subordinated Loan Documents (unless permitted under the JL-BBNC Subordination Agreement), JL Properties Reimbursement Agreement (unless permitted under the JL Properties Subordination Agreement), the DVA Put Agreement or the DVA Note (unless permitted under the DVA Subordination Agreement), the Golisano Holdings Debt (unless permitted under the Subordination Agreement (Golisano Holdings)), the Great Harbor Debt (unless permitted under the Subordination Agreement (Great Harbor)) or the JL-Utah Debt (unless permitted under the Subordination Agreement (JL-Utah)) or any of the leases for the Premises, in each case which would result in a Material Adverse Effect or (iii) the Nutricap Seller Notes.”

 

  3  

 

 

3.           Representations and Warranties; No Default . Each Company hereby represents and warrants that:

 

3.1.       The execution, delivery and performance by such Company of this Amendment (a) are within such Company’s corporate or similar powers and, at the time of execution hereof and have been duly authorized by all necessary corporate and similar action; (b) does not and will not result, in any breach or default under any other document, instrument or agreement to which a Company or any of its Subsidiaries is a party or to which a Company or any of its Subsidiaries, the Premises, the Collateral or any of the property of a Company or any of its Subsidiaries is subject or bound, except for such breaches or defaults which, individually or in the aggregate, have not had, and would not reasonably be expected to result in, a Material Adverse Effect and (c) will not violate any applicable law, statute, regulation, rule, ordinance, code, rule or order.

 

3.2.       This Amendment has been duly executed and delivered for the benefit of or on behalf of each Company and constitutes a legal, valid and binding obligation of each Company, enforceable against such Company in accordance with its terms except (a) as the same may be limited by bankruptcy, insolvency, reorganization moratorium or similar laws now or hereafter in effect relating to creditors rights generally and (b) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

 

3.3.       Both before and after giving effect to this Amendment on the date hereof (a) the representations and warranties of the Companies contained in Section 4.1 of the Note Purchase Agreement and the other Transaction Documents are true, correct and complete on and as of the date hereof as if made on such date (and to the extent any representations and warranties shall relate to the Effective Date or another earlier date, such representation and warranties shall be deemed to be amended to relate to the date hereof), and (b) no Default or Event of Default has occurred and is continuing.

 

4.           Ratification and Confirmation . The Companies hereby ratify and confirm all of the terms and provisions of the Note Purchase Agreement and the other Transaction Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect, except as, and to the extent expressly set forth herein.

 

5.           Condition to Effectiveness . The effectiveness of this Amendment shall be subject to the satisfaction of the following conditions precedent:

 

5.1.       The Purchaser shall have received a fully executed copy of this Amendment.

 

5.2.       The Purchaser shall have received the corresponding, fully executed amendment to the documents evidencing the Permitted Senior Debt, in form and substance satisfactory to the Purchaser.

 

5.3.       The Purchaser shall have received the corresponding, fully executed amendment to the Subordinated Loan Agreement, in form and substance satisfactory to the Purchaser.

 

  4  

 

 

5.4.       All representations and warranties of the Companies contained herein shall be true and correct in all material respects as of the date hereof (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof).

 

5.5.       The Purchaser shall have received all fees and other amounts due and payable to the Purchaser and its counsel in connection with this Amendment, and to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Companies under the Note Purchase Agreement.

 

6.           Miscellaneous .

 

6.1.       Except as otherwise expressly set forth herein, nothing herein shall be deemed to constitute an amendment, modification or waiver of any of the provisions of the Note Purchase Agreement, the Security Agreement or the other Transaction Documents, all of which remain in full force and effect as of the date hereof and are hereby ratified and confirmed. Each Company hereby acknowledges and agrees that nothing contained herein shall be deemed to entitle any Company to consent to, or a waiver, amendment or modification of, any of the terms, conditions, obligations, covenants or agreements contained in the Transaction Documents in similar or different circumstances. This Amendment (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Note Purchase Agreement.

 

6.2.       This Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but all counterparts shall together constitute one instrument. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or electronic mail shall be equally effective as delivery of a manually executed counterpart of this Amendment.

 

6.3.       This Amendment shall be governed by the laws of the State of New York without giving effect to any conflict of law principles and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

6.4.       The Companies agree to pay all reasonable expenses, including legal fees and disbursements, incurred by Purchaser in connection with this Amendment and the transactions contemplated hereby.

 

6.5.       This Amendment shall be deemed a Transaction Document for all purposes of the Note Purchase Agreement and the other Transaction Documents. On and after the date hereof, each reference in the Note Purchase Agreement and the other Transaction Documents to the Note Purchase Agreement, shall mean and be a reference to the Note Purchase Agreement, as modified by this Amendment.

 

6.6.        Each Company, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “ Releasing Parties ”), does hereby fully and completely release, acquit and forever discharge each Indemnified Party of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnified Parties (or any of them) that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “ Prior Related Event ” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any of the terms of this Amendment or any other Transaction Document, (b) any actions, transactions, matters or circumstances related hereto or thereto, (c) the conduct of the relationship between the Purchaser and any Company, or (d) any other actions or inactions by the Purchaser, all on or prior to the date hereof. Each Company acknowledges that the foregoing release is a material inducement to the Purchaser’s decision to enter into this Amendment and to agree to the modifications contemplated hereunder.

 

[Signature Pages Follow.]

 

  5  

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment which shall be deemed to be a sealed instrument as of the date first above written.

 

  COMPANIES
   
  TWINLAB CONSOLIDATED HOLDINGS, INC.
     
  By: /s/ Naomi Whittel
  Name:    Naomi Whittel
  Title:      Chief Executive Officer
   
  TWINLAB HOLDINGS, INC.
   
  By:   /s/ Naomi Whittel
  Name:    Naomi Whittel
  Title:      Chief Executive Officer
   
  TWINLAB CONSOLIDATION CORPORATION
   
  By:   /s/ Naomi Whittel
  Name:    Naomi Whittel
  Title:      Chief Executive Officer
   
  TWINLAB CORPORATION
   
  By:   /s/ Naomi Whittel
  Name:    Naomi Whittel
  Title:      Chief Executive Officer
   
  ISI BRANDS, INC.
   
  By:   /s/ Naomi Whittel
  Name:    Naomi Whittel
  Title:      Chief Executive Officer

 

[Signature Page – Ninth Amendment to Note and Warrant Purchase Agreement]

 

 

 

 

  NUTRASCIENCE LABS, INC.
     
  By: /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Chief Executive Officer
   
  NUTRASCIENCE LABS IP CORPORATION
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Chief Executive Officer
   
   
  ORGANIC HOLDINGS LLC
     
  By: /s/ Naomi Whittel
Name:   Naomi Whittel
  Title:     Sole Manager
   
  RESERVE LIFE ORGANICS, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  RESVITALE, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager

 

[Signature Page – Ninth Amendment to Note and Warrant Purchase Agreement]

 

 

 

 

  RE-BODY, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  INNOVITAMIN ORGANICS, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  ORGANICS MANAGEMENT LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  COCOAWELL, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  FEMBODY, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager

 

[Signature Page – Ninth Amendment to Note and Warrant Purchase Agreement]

 

 

 

 

  RESERVE LIFE NUTRITION, L.L.C.,
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  INNOVITA SPECIALTY DISTRIBUTION, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager
   
  JOIE ESSANCE, LLC
   
  By: ORGANIC HOLDINGS LLC, its sole Member
   
  By:   /s/ Naomi Whittel
  Name:   Naomi Whittel
  Title:     Sole Manager

 

[Signature Page – Ninth Amendment to Note and Warrant Purchase Agreement]

 

 

 

 

  PURCHASER :
   
  PENTA MEZZANINE SBIC FUND I, L.P.
   
  By: Penta Mezzanine SBIC Fund I GP, LLC, its General Partner
     
  By: /s/ Seth D. Ellis
  Name:   Seth D. Ellis
  Title:     Manager

 

[Signature Page – Ninth Amendment to Note and Warrant Purchase Agreement]

 

 

 

Exhibit 10.146

 

EIGHTH AMENDMENT TO NOTE AND WARRANT PURCHASE AGREEMENT

 

This EIGHTH AMENDMENT TO NOTE AND WARRANT AGREEMENT (this “ Amendment ”), dated as of August 11, 2016, but effective as of July 29, 2016, is made by and between TWINLAB CONSOLIDATED HOLDINGS, INC., a Nevada corporation (“ Parent ”), TWINLAB CONSOLIDATION CORPORATION, a Delaware corporation (“ TCC ”), TWINLAB HOLDINGS, INC., a Michigan corporation (“ Twinlab Holdings ”), ISI BRANDS INC., a Michigan corporation (“ ISI Brands ”), and TWINLAB CORPORATION, a Delaware corporation (“ Twinlab Corporation ”), NUTRASCIENCE LABS, INC., a Delaware corporation, NUTRASCIENCE LABS IP CORPORATION., a Delaware corporation, ORGANIC HOLDINGS LLC, a Delaware limited liability company, RESERVE LIFE ORGANICS, LLC, a Delaware limited liability company, RESVITALE, LLC, a Delaware limited liability company, RE-BODY, LLC, a Delaware limited liability company, INNOVITAMIN ORGANICS, LLC, a Delaware limited liability company, ORGANICS MANAGEMENT LLC, a Delaware limited liability company, COCOAWELL, LLC, a Delaware limited liability company, FEMBODY, LLC, a Delaware limited liability company, RESERVE LIFE NUTRITION, L.L.C., a Delaware limited liability company, INNOVITA SPECIALTY DISTRIBUTION, LLC, a Delaware limited liability company, and JOIE ESSANCE, LLC, a Delaware limited liability company (each of the foregoing Persons being referred to herein individually as a “ Company ” and collectively as the “ Companies ”), and JL-MEZZ UTAH, LLC, an Alaska limited liability company, f/k/a JL-BBNC Mezz Utah, LLC (the “ Purchaser ”).

 

WHEREAS, the Companies and the Purchaser are parties to a Note and Warrant Purchase Agreement dated as of January 22, 2015, as amended by that certain First Amendment to Note and Warrant Purchase Agreement, Consent and Joinder dated as of February 4, 2015, that certain Second Amendment to Note and Warrant Purchase Agreement and Consent dated as of April 30, 2015 and that certain Third Amendment to Note and Warrant Puchase Agreement, Limited Consent and Limited Waiver dated as of June 30, 2015 and Fourth Amendment to Note and Warrant Agreement and Limited Consent dated as of September 9, 2015, that certain Limited Waiver to Note and Warrant Purchase Agreement dated as of October 2, 2015, that certain Fifth Amendment to Note and Warrant Purchase Agreement dated as of October 5, 2015, that certain Joinder Agreement dated as of November 10, 2015 and that certain Limited Consent dated as of January 5, 2016, that certain Sixth Amendment to Note and Warrant Purchase Agreement dated as of January 28, 2016, and that certain Seventh Amendment to Note and Warrant Purchase Agreement dated as of April 5, 2016 (as the same may be further amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ Note Purchase Agreement ”).

 

NOW, THEREFORE, in consideration of the promises and the mutual agreements contained in this Amendment, and subject to the terms and conditions set forth herein, each party hereto hereby agrees as follows:

 

1.           Capitalized Terms . Capitalized terms used but not defined herein shall have the meanings set forth in the Note Purchase Agreement.

 

2.           Amendments to Note Purchase Agreement . Subject to the satisfaction of the conditions precedent set forth herein and in reliance on the representations, warranties and covenants of the Companies set forth herein and in the Note Purchase Agreement, each party hereto hereby agrees that the Note Purchase Agreement be and hereby is, amended as follows:

 

 

 

 

2.1.           Amendment to Defined Terms . Section 1 of the Note Purchase Agreement is hereby amended to amend and restate the defined terms “Adjusted EBITDA” and “Little Harbor Debt” in their entirety, respectively, as follows:

 

Adjusted EBITDA ” means EBITDA plus any expenses relating to Acquisitions through the end of Fiscal Year 2015, plus severance payments and other costs relating to permanent headcount reductions, all as determined by GAAP, plus a one-time addback for a non-recurring lease payment to be made in order to terminate the Florida Lease of up to $2,000,000, which termination of the Florida Lease will be on terms and conditions satisfactory to the Purchaser.

 

Little Harbor Debt ” means the “Subordinated Debt” (as that term is defined in the Little Harbor Subordination Agreement) and the “Subordinated Loans” (as that term is defined in the July 2016 Little Harbor Subordination Agreement).

 

2.2.           New Defined Terms . Section 1 of the Note Purchase Agreement is hereby amended by inserting the following defined terms in the appropriate alphabetical order:

 

July 2016 Little Harbor Subordination Agreement ” means the Subordination Agreement dated as of July 21, 2016 between the Purchaser and Little Harbor, LLC, a Nevada limited liability company, and acknowledged by the Companies, as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 

Minimum Liquidity ” means the sum of Revolving Loan Availability (as defined in the Senior Loan Documents) plus cash and cash equivalents that are (a) owned by any Company, and (b) not subject to any Lien other than a Lien in favor of the Senior Lender, excluding, however, any cash and cash equivalents in a specified amount pledged to or held by the Senior Lender to secure a specified Obligation (as defined in the Senior Loan Documents) in that amount. For the avoidance of doubt, cash and cash equivalents that in accordance with the Senior Loan Documents secure the Permitted Senior Debt generally are not excluded except to the extent so specified.

 

2.3.           Amendment to Section 5.12(a) . Section 5.12(a) of the Note Purchase Agreement is hereby amended and restated in its entirety as follows:

 

“(a)           Minimum Adjusted EBITDA . Commencing with the fiscal quarter ending September 30, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall not, as of the end of any measurement period set forth below, permit the Adjusted EBITDA for such measurement period to be less than the amount set forth in the table below opposite such measurement period; provided , however , if (i) no Event of Default exists and (ii) the Fixed Charge Coverage Ratio, as determined in Section 5.12(b), exceeds 1.00x for three consecutive monthly test dates, Minimum Adjusted EBITDA shall no longer be tested under this Section 5.12(a).

 

 

 

 

Measurement Period   Minimum Adjusted EBITDA  
April 1, 2016 to September 30, 2016   $ -1,800,000  
April 1, 2016 to December 31, 2016   $ -2,700,000  
April 1, 2016 to March 31, 2017   $ -3,300,000  
July 1, 2016 to June 30, 2017   $ -2,400,000  
October 1, 2016 to September 30, 2017   $ -2,900,000  
January 1, 2017 to December 31, 2017   $ -1,900,000  
April 1, 2017 to March 31, 2018   $ -1,100,000  
July 1, 2017 to June 30, 2018   $ 0  
October 1, 2017 to September 30, 2018   $ 700,000  
January 1, 2018 to December 31, 2018   $ 1,400,000”  

 

2.4.           Amendment to Section 5.12(b) . Section 5.12(b) of the Note Purchase Agreement is hereby amended by replacing Section 5.12(b) in its entirety with the following:

 

“(b)           Fixed Charge Coverage Ratio . Commencing August 31, 2016 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall not, as of the end of any month, permit the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date to be less than 1.00x; provided , however , that until such time that the Fixed Charge Coverage Ratio for the period of trailing twelve months most recently ended on or prior to such date does exceed 1.00x for three consecutive monthly test dates, compliance shall not be required with respect to the Fixed Charge Coverage Ratio financial covenant in this Section 5.12(b) but such financial covenant shall still be tested as of the end of each month.”

 

2.5.           Amendment to Section 5.12(c) . Section 5.12(c) of the Note Purchase Agreement is hereby amended by replacing Section 5.12(c) in its entirety with the following:

 

“(c)           Minimum Liquidity . Commencing January 1, 2017 and until such time as all Obligations are paid, satisfied and discharged in full, the Companies shall at all times, as tested as of the end of any month, have Minimum Liquidity for the test date during the applicable period equal to or in excess of than the amount set forth in the table below opposite such applicable period.

 

Applicable Period   Minimum Liquidity  
January 1, 2017 to March 31, 2017   $ 500,000  
April 1, 2017 to June 30, 2017   $ 1,000,000  
July 1, 2017 and all times thereafter   $ 1,500,000”  

 

2.6.           Amendment to Section 6.11 . Section 6.11 of the Note Purchase Agreement is hereby amended by replacing Section 6.11 in its entirety with the following:

 

6.11         Entering Into or Modification of Certain Agreements

 

The Companies and their Subsidiaries shall not amend, restate, supplement or otherwise modify (or permit or consent to any amendment, restatement, supplement or modification of) the terms of (i) its articles or certificate of incorporation, bylaws, any agreement between or among any of the holders of any Company’s or any of its Subsidiaries’ Equity Interests, any other organizational document, in each case which would be materially adverse to the Purchaser and (ii) any of the Transaction Documents, the documents and/or instruments evidencing the Permitted Senior Debt (unless permitted under the Subordination Agreement), the documents and/or instruments evidencing the Little Harbor Debt (unless permitted under the Little Harbor Subordination Agreement or the July 2016 Little Harbor Subordination Agreement, as applicable), the Subordinated Loan Documents (unless permitted under the JL-BBNC Subordination Agreement), JL Properties Reimbursement Agreement (unless permitted under the JL Properties Subordination Agreement), the DVA Put Agreement or the DVA Note (unless permitted under the DVA Subordination Agreement), the Golisano Holdings Debt (unless permitted under the Subordination Agreement (Golisano Holdings)), the Great Harbor Debt (unless permitted under the Subordination Agreement (Great Harbor)) or the JL-Utah Debt (unless permitted under the Subordination Agreement (JL-Utah)) or any of the leases for the Premises, in each case which would result in a Material Adverse Effect or (iii) the Nutricap Seller Notes.”

 

 

 

 

3.          Representations and Warranties; No Default . Each Company hereby represents and warrants that:

 

3.1.      The execution, delivery and performance by such Company of this Amendment (a) are within such Company’s corporate or similar powers and, at the time of execution hereof and have been duly authorized by all necessary corporate and similar action; (b) does not and will not result, in any breach or default under any other document, instrument or agreement to which a Company or any of its Subsidiaries is a party or to which a Company or any of its Subsidiaries, the Premises, the Collateral or any of the property of a Company or any of its Subsidiaries is subject or bound, except for such breaches or defaults which, individually or in the aggregate, have not had, and would not reasonably be expected to result in, a Material Adverse Effect and (c) will not violate any applicable law, statute, regulation, rule, ordinance, code, rule or order.

 

3.2.      This Amendment has been duly executed and delivered for the benefit of or on behalf of each Company and constitutes a legal, valid and binding obligation of each Company, enforceable against such Company in accordance with its terms except (a) as the same may be limited by bankruptcy, insolvency, reorganization moratorium or similar laws now or hereafter in effect relating to creditors rights generally and (b) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefor may be brought.

 

3.3.      Both before and after giving effect to this Amendment on the date hereof (a) the representations and warranties of the Companies contained in Section 4.1 of the Note Purchase Agreement and the other Transaction Documents are true, correct and complete on and as of the date hereof as if made on such date (and to the extent any representations and warranties shall relate to the Effective Date or another earlier date, such representation and warranties shall be deemed to be amended to relate to the date hereof), and (b) no Default or Event of Default has occurred and is continuing.

 

4.           Ratification and Confirmation . The Companies hereby ratify and confirm all of the terms and provisions of the Note Purchase Agreement and the other Transaction Documents and agree that all of such terms and provisions, as amended hereby, remain in full force and effect, except as, and to the extent expressly set forth herein.

 

5.           Condition to Effectiveness . The effectiveness of this Amendment shall be subject to the satisfaction of the following conditions precedent:

 

5.1.      The Purchaser shall have received a fully executed copy of this Amendment.

 

5.2.      The Purchaser shall have received the corresponding, fully executed amendment to the documents evidencing the Permitted Senior Debt, in form and substance satisfactory to the Purchaser.

 

 

 

 

5.3.       All representations and warranties of the Companies contained herein shall be true and correct in all material respects as of the date hereof (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof).

 

5.4.       The Purchaser shall have received all fees and other amounts due and payable to the Purchaser and its counsel in connection with this Amendment, and to the extent invoiced, reimbursement or payment of all out-of-pocket expenses required to be reimbursed or paid by the Companies under the Note Purchase Agreement.

 

6.           Miscellaneous .

 

6.1.       Except as otherwise expressly set forth herein, nothing herein shall be deemed to constitute an amendment, modification or waiver of any of the provisions of the Note Purchase Agreement, the Security Agreement or the other Transaction Documents, all of which remain in full force and effect as of the date hereof and are hereby ratified and confirmed. Each Company hereby acknowledges and agrees that nothing contained herein shall be deemed to entitle any Company to consent to, or a waiver, amendment or modification of, any of the terms, conditions, obligations, covenants or agreements contained in the Transaction Documents in similar or different circumstances. This Amendment (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Note Purchase Agreement.

 

6.2.       This Amendment may be executed in any number of counterparts, each of which, when executed and delivered, shall be an original, but all counterparts shall together constitute one instrument. Delivery of an executed counterpart of a signature page of this Amendment by facsimile or electronic mail shall be equally effective as delivery of a manually executed counterpart of this Amendment.

 

6.3.       This Amendment shall be governed by the laws of the State of New York without giving effect to any conflict of law principles and shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 

6.4.       The Companies agree to pay all reasonable expenses, including legal fees and disbursements, incurred by Purchaser in connection with this Amendment and the transactions contemplated hereby.

 

6.5.       This Amendment shall be deemed a Transaction Document for all purposes of the Note Purchase Agreement and the other Transaction Documents. On and after the date hereof, each reference in the Note Purchase Agreement and the other Transaction Documents to the Note Purchase Agreement, shall mean and be a reference to the Note Purchase Agreement, as modified by this Amendment.

 

6.6.        Each Company, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees (collectively, “ Releasing Parties ”), does hereby fully and completely release, acquit and forever discharge each Indemnified Party of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Indemnified Parties (or any of them) that directly or indirectly arise out of, are based upon or are in any manner connected with any Prior Related Event. “ Prior Related Event ” means any transaction, event, circumstance, action, failure to act, occurrence of any type or sort, whether known or unknown, which occurred, existed, was taken, was permitted or begun in accordance with, pursuant to or by virtue of (a) any of the terms of this Amendment or any other Transaction Document, (b) any actions, transactions, matters or circumstances related hereto or thereto, (c) the conduct of the relationship between the Purchaser and any Company, or (d) any other actions or inactions by the Purchaser, all on or prior to the date hereof. Each Company acknowledges that the foregoing release is a material inducement to the Purchaser’s decision to enter into this Amendment and to agree to the modifications contemplated hereunder.

 

[Signature Pages Follow.]

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Amendment which shall be deemed to be a sealed instrument as of the date first above written.

 

COMPANIES

 

      TWINLAB CONSOLIDATION CORPORATION  
           
      By: /s/ Naomi Whittel (Seal)
      Name: Naomi Whittel  
      Title: Chief Executive Officer  
           
TWINLAB CONSOLIDATED HOLDINGS, INC.     TWINLAB HOLDINGS, INC.  
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Chief Executive Officer       Title: Chief Executive Officer    
             
TWINLAB CORPORATION        ISI BRANDS, INC.  
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Chief Executive Officer       Title: Chief Executive Officer    
             
NUTRASCIENCE LABS, INC.     NUTRASCIENCE LABS IP CORPORATION  
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Chief Executive Officer        Title: Chief Executive Officer    
             
ORGANIC HOLDINGS LLC     RESERVE LIFE ORGANICS, LLC  
             
By: /s/ Naomi Whittel   (Seal)   By ORGANIC HOLDINGS LLC,  
Name: Naomi Whittel     its sole Member  
Title: Sole Manager          
        By: /s/ Naomi Whittel (Seal)
        Name: Naomi Whittel  
        Title: Sole Manager  

 

[Signature Page – Eighth Amendment to Note and Warrant Purchase Agreement] 

 

 

 

 

RESVITALE, LLC     RE-BODY, LLC
       
By ORGANIC HOLDINGS LLC,     By ORGANIC HOLDINGS LLC,
its sole Member     its sole Member
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Sole Manager     Title: Sole Manager  
             
INNOVITAMIN ORGANICS, LLC     ORGANICS MANAGEMENT LLC
       
By ORGANIC HOLDINGS LLC,     By ORGANIC HOLDINGS LLC,
its sole Member     its sole Member
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Sole Manager     Title: Sole Manager  
             
COCOAWELL, LLC     FEMBODY, LLC
       
By ORGANIC HOLDINGS LLC,     By ORGANIC HOLDINGS LLC,
its sole Member     its sole Member
             
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Sole Manager     Title: Sole Manager  
             
RESERVE LIFE NUTRITION, L.L.C.     INNOVITA SPECIALTY DISTRIBUTION, LLC
       
By ORGANIC HOLDINGS LLC,     By ORGANIC HOLDINGS LLC,
its sole Member     its sole Member
           
By: /s/ Naomi Whittel (Seal)   By: /s/ Naomi Whittel (Seal)
Name: Naomi Whittel     Name: Naomi Whittel  
Title: Sole Manager     Title: Sole Manager  
             
JOIE ESSANCE, LLC          
             
By ORGANIC HOLDINGS LLC,          
its sole Member          
             
By: /s/ Naomi Whittel (Seal)        
Name: Naomi Whittel          
Title: Sole Manager          

 

[Signature Page – Eighth Amendment to Note and Warrant Purchase Agreement]

 

 

 

 

  PURCHASER :
   
  JL-MEZZ UTAH, LLC ,
  an Alaska Limited Liability Company
     
  By: /s/ Jonathan B. Rubini
  Name: Jonathan B. Rubini
  Title: Managing Member

 

[Signature Page – Eighth Amendment to Note and Warrant Purchase Agreement]